JPRN-UMIN000044150已完成4 期
Clinical outcomes of dry-preserved amniotic membrane allograft transplant for ocular surface disease - DAMAT for OSD
Peregrine Eye and Laser Institute Research Section0 个研究点目标入组 30 人开始时间: 2021年5月9日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
Improved ocular comfort was reported 97%. Mean ocular discomfort score decreased from 3.30 to 1.24 while mean photophobia score decreased from 3.15 to 1.27. Mean LogMAR BCVA improved from 0.42 to 0.25. The AM and SCL remained in position for 94% of eyes. Complete corneal epithelialization was observed in all eyes immediately after SCL removal.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects were excluded from the study if any of the following criteria was fulfilled, corneal or scleral perforation or impending perforation, subjects with recent or active infection, subjects not able to understand the character and individual consequences of the investigation, and participation in other clinical research within the last 8 weeks.
研究者
相似试验
已完成
不适用
Optimizing the Ocular Surface Prior to Cataract SurgeryCorneal Dystrophy, Epithelial Basement MembraneNCT02766907Tissue Tech Inc.20
撤回
早期 1 期
Clinical Efficacy of Amniotic Membrane Extract Eye Drops in Dry Eye TreatmentDry Eyes ChronicNCT05169931University of California, Los Angeles
已完成
早期 1 期
Safety Study of a Sutureless Amniotic Membran Transplantation to Treat Ocular Surface Disorders (Expanded Access)Corneal UlcersCorneal MeltingNCT02168790Klinikum Chemnitz gGmbH7
终止
2 期
Amniotic Membrane Visio-AMTRIX in Recurrent Macular HoleMacular HolesRetinal DetachmentNCT05191628TBF Genie Tissulaire12
已完成
不适用
Amniotic membrane extract eye drops for eye surface diseases.The efficacy of amniotic membrane extract in the treatment of ocular surface diseases with inflammation and epithelial disorders.Eye - Diseases / disorders of the eyeACTRN12610000014055Zuguo Liu50